Archives
Uridine, Trisodium Salt in RNA Genome Engineering
2026-09-11
Uridine, Trisodium Salt can strengthen the upstream RNA supply chain behind emerging RNA-mediated genome engineering while supporting distinct vascular biology applications. This article connects nucleotide metabolism, PRINT-style transgene insertion, assay design, and translational decision-making without overstating what the reagent can accomplish.
4-MUG Workflows for Lysosomal Enzyme Assays
2026-09-11
Use 4-MUG as a sensitive fluorogenic readout for β-glucosidase and β-glucocerebrosidase activity across lysate, cell-based, kinetic, and screening workflows. This guide connects practical assay optimization with emerging GBA1 mRNA-LNP research while clarifying what the substrate can—and cannot—prove.
4-MUG for β-Glucocerebrosidase Activity Assays
2026-09-10
Use 4-MUG to convert β-glucosidase and β-glucocerebrosidase hydrolysis into a sensitive 4-methylumbelliferone fluorescence readout. This workflow is especially useful for comparing GBA1 mRNA delivery, lysosomal enzyme function, disease-model lysates, and inhibitor or activator screens while keeping assay controls and pH effects visible.
12-O-tetradecanoyl phorbol-13-acetate Workflow
2026-09-10
Use 12-O-tetradecanoyl phorbol-13-acetate (TPA) as a controllable protein kinase C and ERK/MAPK stimulus for time-resolved signaling, kinase assays, and skin cancer model design. This guide connects practical stock handling with orthogonal readouts and a cautious extension into macrophage signal-transduction research.
ISRIB (trans-isomer) for ER Stress Workflows
2026-09-09
ISRIB (trans-isomer) provides a reversible way to test how PERK-linked translational control shapes ER stress, apoptosis, and ATF4 biology. This workflow-focused guide connects eIF2B activation with hepatic stellate cell assays while clearly separating reference evidence from practical starting conditions.
(-)-JQ1: The Control That Clarifies BRD4 Biology
2026-09-09
(-)-JQ1 is more than an inactive companion to active BET inhibitors: it is a strategic control for separating BRD4-dependent biology from solvent effects, nonspecific cytotoxicity, and model-specific stress responses. This article connects rigorous JQ1 stereoisomer control design with emerging evidence on the BRD4/AKT/SIRT3 axis in hyperoxia-induced lung injury.
Midecamycin: Mechanism to Translational Strategy
2026-09-08
A thought-leadership analysis of Midecamycin that connects ribosomal mechanism, macrolide biosynthesis, assay design, resistance interpretation, and translational strategy for microbiology researchers.
Z-LEHD-FMK for Caspase-9 Apoptosis Studies
2026-09-08
Z-LEHD-FMK is an irreversible caspase-9 inhibitor for testing whether mitochondrial apoptosis drives treatment-associated cell death. This guide translates its use into practical apoptosis assay, cancer research, and neuroprotection workflows, with formulation guidance and troubleshooting strategies.
Cell Lysis Buffer for WB and IP in CAF Studies
2026-09-07
Translate cancer-associated fibroblast signaling into reliable Western blot, immunoprecipitation, and co-IP workflows with a non-denaturing extraction system. This guide shows how K1123 supports phosphorylation preservation, protein-interaction studies, and troubleshooting across prostate cancer and tumor-microenvironment samples.
L. plantarum P101 Activates AMPK in Alcoholic Steatosis
2026-09-07
A 2025 mouse study shows that Lactiplantibacillus plantarum P101 reduced alcohol-induced hepatic lipid accumulation while activating AMPK, with associated changes in gut microbiota and serum metabolites. Pharmacological AMPK inhibition weakened these benefits, supporting a mechanistic role for AMPK while indicating that microbiota and metabolite correlations require further causal testing.
NMDA Workflows for Excitotoxicity Research
2026-09-05
NMDA provides a controlled way to activate NMDA receptors and connect early calcium loading with later oxidative stress, ferroptosis, and retinal ganglion cell injury. This practical workflow translates the BMP4-GPX4 glaucoma findings into assay choices for excitotoxicity research and neurodegenerative disease models.
Deferasirox in Iron-Dependent Cell Death Assays
2026-09-04
Deferasirox is an oral iron chelator that can be used as a mechanistic probe for iron-dependent stress, lysosomal dysfunction, and metabolic vulnerability. This workflow connects iron handling with the TCF25–V-ATPase response to glucose starvation while separating validated findings from testable cancer-research hypotheses.
Primidone and CYP19: Evidence from Antiepileptic Screening
2026-09-04
Jacobsen, Halling-Sørensen, and Birkved evaluated 12 antiepileptic drugs for inhibition of human aromatase CYP19 and found that Primidone, also known as Mysoline, did not inhibit the enzyme in their microsomal assay. The study provides a useful framework for separating CYP19-related endocrine mechanisms from other pharmacological activities and for interpreting combination-therapy risks.
PR-619: Deubiquitylating Enzymes Inhibitor Workflows
2026-09-03
PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor for tracking ubiquitin accumulation without directly blocking proteasomal catalysis. This guide translates its chemistry into practical workflows for ubiquitination pathway research, autophagy activation assays, cancer biology research, and neurodegenerative disease models.
DiscoveryProbe Natural Product Library Plus: Assay Design
2026-09-03
Discover how the DiscoveryProbe Natural Product Library Plus can support evidence-driven natural product screening for drug discovery. This guide translates CpAdhE study findings into practical HTS, HCS, and orthogonal validation decisions.
724 records 7/49 page Previous Next First page 上5页 678910 下5页 Last page